Steven M. Fruchtman - 07 Feb 2023 Form 4 Insider Report for Onconova Therapeutics, Inc. (TRAW)

Role: PRESIDENT, CHIEF EXECUTIVE OFF, Director
Signature: /s/ Mark Guerin, Attorney-in-Fact
Issuer symbol: TRAW
Transactions as of: 07 Feb 2023
Net transactions value: -$9,489
Form type: 4
Filing time: 08 Feb 2023, 17:00:34 UTC
Previous filing: 04 Aug 2022
Next filing: 14 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ONTX	Common Stock	Options Exercise		+21,320	+82%		47,454	07 Feb 2023	Direct	F1
transaction	ONTX	Common Stock	Tax liability	$9,489	-6,977	-15%	$1.36	40,477	07 Feb 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ONTX	Restricted Stock Units	Options Exercise	$0	-21,320	-33%	$0.000000	42,640	07 Feb 2023	Common Stock	21,320		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	On February 7, 2022 the reporting person was granted 63,960 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.